Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GBT Technologies is a publicly traded microcap technology company that develops and licenses patented technologies spanning artificial intelligence, IoT, mesh networking, semiconductors, cybersecurity, and selected digital health applications. Within healthcare, the company has worked on telehealth, AI-based health advisory software, and remote human-vitals monitoring concepts such as Hippocrates, Avant!, and qTerm. More recently, GBT has also used its Cube Wellness subsidiary to deploy AI-enabled digital wellness machines, positioning itself around wellness infrastructure rather than drug development. The company is not a traditional biotech or pharmaceutical developer and does not appear to have a therapeutic drug pipeline. For a life sciences analyst, GBT is best categorized as a health-adjacent digital health and wellness technology company rather than a biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GBT Technologies.